Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.

Firooz A, Ghandi N, Hallaji Z, Chams-Davatchi C, Valikhani M, Karbakhsh Davari M.

Arch Dermatol. 2008 Sep;144(9):1143-7. doi: 10.1001/archderm.144.9.1143.

PMID:
18794458
2.

Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

Sanderson J, Ansari A, Marinaki T, Duley J.

Ann Clin Biochem. 2004 Jul;41(Pt 4):294-302. Review.

3.

TPMT testing before azathioprine therapy?

[No authors listed]

Drug Ther Bull. 2009 Jan;47(1):9-12. doi: 10.1136/dtb.2008.12.0033. Review.

PMID:
19129430
4.

[Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease].

Gisbert JP, González-Lama Y, Maté J.

Gastroenterol Hepatol. 2006 Nov;29(9):568-83. Review. Spanish.

PMID:
17129552
5.

Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy.

Baker DE.

Rev Gastroenterol Disord. 2003 Summer;3(3):150-7. Review.

PMID:
14502119
6.

Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.

Clunie GP, Lennard L.

Rheumatology (Oxford). 2004 Jan;43(1):13-8. Review.

7.

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.

Gearry RB, Barclay ML.

J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. Review.

PMID:
16048561
8.

Clinical utility of thiopurine S-methyltransferase genotyping.

Corominas H, Baiget M.

Am J Pharmacogenomics. 2004;4(1):1-8. Review.

PMID:
14987117
9.

Oral pemphigus vulgaris: a case report with review of the literature.

Dagistan S, Goregen M, Miloglu O, Cakur B.

J Oral Sci. 2008 Sep;50(3):359-62. Review.

10.

Bioequivalence of azathioprine products.

Baker DE.

Rev Gastroenterol Disord. 2003 Fall;3(4):219-23. Review.

PMID:
14668694
11.

Azathioprine for atopic dermatitis.

Meggitt SJ, Reynolds NJ.

Clin Exp Dermatol. 2001 Jul;26(5):369-75. Review.

PMID:
11488818
12.

Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.

Mignogna MD, Lo Muzio L, Mignogna RE, Carbone R, Ruoppo E, Bucci E.

J Oral Pathol Med. 2000 Apr;29(4):145-52. Review.

PMID:
10766391
13.

Optimizing immunomodulator therapy for inflammatory bowel disease.

Dubinsky MC.

Curr Gastroenterol Rep. 2003 Dec;5(6):506-11. Review.

PMID:
14602061
14.

[Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine].

Bessard G, Hardy G, Chartier A, Stanke-Labesque F.

Therapie. 2004 Jan-Feb;59(1):71-5. Review. French.

PMID:
15199672
15.

Treatment strategies for pemphigus vulgaris in Japan.

Hashimoto T.

Expert Opin Pharmacother. 2008 Jun;9(9):1519-30. doi: 10.1517/14656566.9.9.1519 . Review.

PMID:
18518782
16.

Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature.

Yeter KC, Afkhami M, Brynes RK, Quismorio FP Jr.

Lupus. 2013 Dec;22(14):1526-8. doi: 10.1177/0961203313504636. Review.

PMID:
24029750
17.

The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.

Allen KJ, Wolverton SE.

J Drugs Dermatol. 2007 Sep;6(9):883-9. Review.

PMID:
17941359
18.

Safety issues in the management of autoimmune hepatitis.

Czaja AJ.

Expert Opin Drug Saf. 2008 May;7(3):319-33. doi: 10.1517/14740338.7.3.319 . Review.

PMID:
18462189
19.

The thiopurines: an update.

Coulthard S, Hogarth L.

Invest New Drugs. 2005 Dec;23(6):523-32. Review.

PMID:
16267626
20.

[Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity].

Gisbert JP, Gomollón F, Maté J, Pajares JM.

Rev Clin Esp. 2002 Oct;202(10):555-62. Review. Spanish. No abstract available.

PMID:
12361557
Items per page

Supplemental Content

Support Center